Together, these mechanisms not only promote weight loss but also help improve overall metabolic health
"These findings may inform shared decision making when considering GLP- 1 receptor agonist therapy and highlight the need for further evaluation of dermatological outcomes in future studies." The study involved a large number of people: 12,004 patients using GLP-1 drugs were compared to 15,221 using SGLT-2 inhibitors, with an additional 11,964 GLP-1 users compared to 11,233 using DPP-4 inhibitors
While Retatrutide is not yet approved and poses some risks, weighing these against potential benefits with a healthcare provider is crucial
If they lose muscle on the drug, then gain back mostly fat, the body underneath is worse off
Or a Different Beast Entirely
It has demonstrated significant weight loss, achieving a reduction of up to 24.2%